However, the drug regulatory authorities have also documented rare and occasional severe side effects associated with using GLP-1 agonists, especially GI disease
PEAK accepts Anthem, Cigna, Aetna, UnitedHealthcare, Sentara, and TRICARE, and does not accept Medicare or Medicaid plans
Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
Some compounded formulations include additional ingredients
Patients prescribed GLP-1 receptor agonists should: Receive proper training on injection technique Be monitored regularly for efficacy and adverse effects Report any suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app) Understand that these medicines are part of a comprehensive treatment plan including diet and lifestyle modifications The synthetic manufacturing process and stringent regulatory oversight ensure that GLP-1 medicines meet the highest pharmaceutical standards, with no risk of venom-related contamination or variability
GLP-1 receptor agonists function by mimicking a hormone that targets areas of the brain involved in appetite regulation
